Antalgija - Company finances
|
EUR
|
2021
From: 2021-07-09
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | - | 158,241 | 205,628 | 323,674 |
| Profit before tax | - | - | - | - | -182,162 |
| Net profit | -3,857 | -7,681 | -151,499 | -188,707 | -182,162 |
| Equity | 46,143 | 38,463 | 26,964 | 110,256 | 103,095 |
| Liabilities | 8,285 | 1,523 | 22,057 | 178,760 | 157,522 |
| Non-current assets | 14,019 | 14,019 | 14,744 | 232,902 | 209,124 |
| Current assets | 40,161 | 25,923 | 33,939 | 55,563 | 50,448 |
| Total assets | 54,180 | 39,942 | 48,683 | 288,465 | 259,572 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 31,797 | 42,656 | 57,706 |
| Social insurance contributions | - | - | 34,096 | 46,541 | 70,689 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | - | +29.9% | +57.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -7.1% | -19.2% | -311.2% | -65.4% | -70.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -8.4% | -20.0% | -561.9% | -171.2% | -176.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -95.7% | -91.8% | -56.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -56.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.0 | 0.8 | 1.6 | 1.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 9,639 | 10,239 | 11,129 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Antalgija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-27 | 2026-08-09 | 0.99 |
| 2026-07-26 | 2026-07-26 | 211.64 |
| 2026-07-23 | 2026-07-25 | 212.63 |
| 2026-07-19 | 2026-07-22 | 211.64 |
| 2026-06-16 | 2026-06-25 | 354.03 |
| 2026-05-17 | 2026-06-08 | 0.01 |
Antalgija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-25 | 2025-11-25 | 260.66 |
| 2025-11-24 | 2025-11-24 | 185.8 |
| 2025-05-29 | 2025-06-25 | 0.19 |
| 2025-04-28 | 2025-05-20 | 0.19 |
| 2025-04-02 | 2025-04-26 | 0.19 |
| 2025-01-30 | 2025-02-25 | 0.07 |
| 2025-01-24 | 2025-01-24 | 0.07 |
| 2024-12-30 | 2025-01-23 | 0.11 |
| 2024-12-13 | 2024-12-27 | 32.62 |
| 2024-12-05 | 2024-12-12 | 32.54 |
| 2024-12-03 | 2024-12-04 | 32.5 |
| 2024-12-01 | 2024-12-02 | 32.49 |
| 2024-11-29 | 2024-11-30 | 32.48 |
| 2024-11-28 | 2024-11-28 | 31.19 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Antalgija, UAB (code 305821114) is a Private Limited Liability Company engaged in Medical specialists activities. In 2025, the company generated revenue of €323.7K, up 57.4% year on year and 104.5% over two years, showing a strong top-line expansion from €158.2K in 2023 and €205.6K in 2024. Despite this growth, profitability remained negative: net loss was €182.2K in 2025, compared with €151.5K in 2023 and €188.7K in 2024. The 2025 profit margin was -56.3%, an improvement versus the very weak margins seen in prior years, but still indicating a sizeable operating deficit. At year-end 2025, total assets stood at €259.6K, supported by equity of €103.1K and liabilities of €157.5K. Long-term assets accounted for €209.1K, while short-term assets were €50.4K. Key efficiency indicators show asset turnover of 1.25x, debt-to-equity of 1.53, and revenue per employee of €11.2K, with a negative profit per employee of €6.3K. Overall, the company scaled revenue materially, but losses remained significant in 2025.